L’Oréal Egypt, a prominent global beauty company, has declared the initiation of the 9th edition of its annual flagship Skin and Hair Summit.
This event, organized by the company’s Medical Beauty Division, seeks to present and exchange knowledge about the latest advancements, innovations, and research in support of the field of dermatology, with a specific focus on skin and hair care.
The summit was granted credit hours by the CPD institute and took place at the Salah El-Din Citadel, a renowned historical site in Egypt, and was attended by over 1000 leading dermatologists from Egypt and the Middle East.
The summit included four informative panels on skin and hair health. Dr. Anna Kelly presented on hair science and androgenetic alopecia, while Professor May El Samahy concentrated on progress in acne treatment.
Professor Samia Essmat led a panel on hyperpigmentation, during which La Roche Posay Egypt unveiled a new product. The summit concluded with an interactive anti-aging session featuring Professor Shady Mahmoud and Dr. Amin Sharobeem.
According to the Zawya website, alongside the Skin and Hair Summit, L’Oréal Egypt, under its international brand La Roche Posay, revealed its latest skincare innovation, a new pioneering formula for pigmentary disorders called the new MELAB3. This breakthrough patented molecule, born out of 18 years of thorough research and screenings in addition to 121 scientific studies, is designed to address localized pigmentation issues leading to age spots and post-acne marks.
Mela B3 Serum, powered by Melasyl™ with 10% Niacinamide, is the first dermatological solution for discoloration and dark spots. This anti-aging serum visibly reduces a variety of skin discoloration issues, such as sunspots, age spots, post-acne marks, and even the most stubborn dark spots, with long-lasting results while preserving the natural tone of all skin types.
Dave Hughes, Managing Director of L’Oréal Egypt, expressed his delight at launching the 9th edition of the Skin and Hair Summit as a demonstration of the company’s dedication to providing a platform for knowledge exchange and innovation.
He emphasized the event’s role in empowering the beauty industry and fostering collaboration among experts. Hughes also expressed pride in welcoming a dedicated group of doctors passionate about staying at the forefront of innovation, attributing L’Oréal’s commitment to R&D as instrumental in driving these advancements.
Addressing the launch of MELAB3, Sandrine Japhet-Sibboni, LDB General Manager, highlighted that hyperpigmentation has long been a skincare concern for nearly half of the world’s population.
She noted L’Oréal’s leadership in advanced beauty sciences over the past century, with 35 years of dedicated research into skin pigmentation. She expressed excitement at introducing MELAB3 through La Roche Posay, believing it will have a transformative impact on consumers by not only addressing hyperpigmentation but also improving overall skin health.
It is important to note that L’Oréal’s annual Skin and Hair Summit has achieved significant success over the years, affirming the company’s social responsibility, robust strategy, and unwavering commitment to advancing scientific research in the field of skin and hair care. Furthermore, this year’s summit aimed to reach nearly all dermatologists in Egypt, underscoring its importance as an effective scientific platform.
